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Introduction
Some amphibians, as well as teleost fish, have a robust capacity 
to regenerate their hearts after injury throughout their life (Poss 
et al., 2002). Adult zebrafish, for example, can fully regenerate 
their heart without scar formation after up to 20% of the ventri-
cle has been resected. This regenerative response is thought to 
occur primarily through dedifferentiation and proliferation of 
existing myocytes (Jopling et al., 2010; Kikuchi et al., 2010). 
Recent studies have demonstrated that the embryonic mamma-
lian heart is also capable of mounting a hyperplastic response to 
injury but that this is lost rapidly after birth (Drenckhahn et al., 
2008; Porrello et al., 2011). Although some studies have sug-
gested that the adult mammalian heart possesses a very limited 
capacity for new cardiomyocyte formation, the source has been 
postulated to be endogenous cardiac stem cells, not existing 
myocytes  (Pasumarthi  and  Field,  2002;  Hsieh  et  al.,  2007; 
Bergmann et al., 2009). Thus, the vast majority of cardiac myo-
cytes permanently exits the cell cycle soon after birth in mam-
mals, and, when adult cardiac myocytes (ACMs) are subjected 
to a growth stimulus, they undergo an increase in cell size 
(hypertrophy) but do not proliferate. The molecular basis for 
the postmitotic state of ACMs is unknown, but the subset of 
E2F-dependent genes specifically involved in regulating G2/M 
and cytokinesis is not up-regulated after growth stimuli in ACMs. 
The mechanisms that irreversibly silence these genes are un-
known; however, stable transcriptional silencing in eukaryotic 
cells is often caused by specific histone modifications that result 
in heterochromatin formation around a gene, making it inacces-
sible to transcriptional machinery.
T
he mammalian heart loses its regenerative potential 
soon  after  birth.  Adult  cardiac  myocytes  (ACMs) 
permanently exit the cell cycle, and E2F-dependent 
genes are stably silenced, although the underlying mech-
anism is unclear. Heterochromatin, which silences genes 
in  many  biological  contexts,  accumulates  with  cardiac   
differentiation. H3K9me3, a histone methylation charac-
teristic of heterochromatin, also increases in ACMs and at 
E2F-dependent  promoters.  We  hypothesize  that  genes 
relevant for cardiac proliferation are targeted to hetero-
chromatin by retinoblastoma (Rb) family members inter-
acting  with  E2F  transcription  factors  and  recruiting 
heterochromatin protein 1 (HP1) proteins. To test this   
hypothesis, we created cardiac-specific Rb and p130   
inducible double knockout (IDKO) mice. IDKO ACMs 
showed a decrease in total heterochromatin, and cell   
cycle genes were derepressed, leading to proliferation of 
ACMs. Although Rb/p130 deficiency had no effect on total 
H3K9me3 levels, recruitment of HP1- to promoters was 
lost. Depleting HP1- up-regulated proliferation-promoting 
genes in ACMs. Thus, Rb and p130 have overlapping roles 
in maintaining the postmitotic state of ACMs through their 
interaction with HP1- to direct heterochromatin formation 
and silencing of proliferation-promoting genes.
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The structure of Pc2 bound to H3K27me3 is very similar to that 
of HP1-binding H3K9me3. Functionally, the Pc2-containing 
PRC1 complex stabilizes the repression of chromatin structure 
by antagonizing the switch–sucrose nonfermentable complex 
(Shao et al., 1999).
The mechanisms whereby distinct histone modifications 
or chromatin is localized to specific genes are an area of in-
tense research. Retinoblastoma (Rb) family members can direct 
H3K9me3 and H3K27me3 to specific promoter regions, pro-
viding a means to target cell cycle genes to heterochromatin 
through their ability to interact with E2F family members and 
recruit repressive chromatin remodeling factors to E2F-dependent 
promoters (Nielsen et al., 2001; Blais et al., 2007). Rb can po-
tentially associate with multiple chromatin remodeling factors, 
including histone deacetylases (Luo et al., 1998; Magnaghi-
Jaulin et al., 1998), Suv39h1 (Nielsen et al., 2001), HP1 (Nielsen 
et al., 2001), and Pc2 (Dahiya et al., 2001). In senescent cells, 
Rb  promotes  heterochromatin  formation  at  E2F-responsive 
genes by recruiting HP1 to H3K9 trimethylated promoters, 
thereby producing a permanent insensitivity to mitogenic sig-
nals (Nielsen et al., 2001; Narita et al., 2003). Pc2 has also been 
implicated in the repression of the E2F-dependent genes and 
can cooperate with Rb to inhibit the expression of cyclin A and 
cdc2 (Dahiya et al., 2001).
Despite numerous descriptive studies (Soonpaa and Field, 
1994; Li et al., 1996; Bergmann et al., 2009; Walsh et al., 2010) 
characterizing the limited ability of ACMs to proliferate, almost 
no mechanistic data exist to explain why ACMs do not reenter 
the cell cycle in response to mitogenic stimuli. We have impli-
cated Rb family members in mediating cardiac cell cycle exit 
(MacLellan et al., 2005), but what role they play in maintaining 
the postmitotic state of ACMs and the mechanisms underlying 
their  importance  are  unknown.  Indeed,  recent  studies  have 
questioned whether Rb family members actually play any role 
in the maintenance of terminal differentiation (Camarda et al., 
2004; Huh et al., 2004; Mantela et al., 2005; Blais et al., 2007). 
Here, we demonstrate that heterochromatin accumulation and 
targeting of proliferation-promoting genes to these transcrip-
tionally silent regions are the molecular basis of the postmitotic 
phenotype of ACMs. Rb and p130 target E2F-dependent genes 
to heterochromatin in ACMs, silencing these proliferation- 
promoting genes through the recruitment of HP1- to H3K9 tri-
methylated promoters.
Results
Silencing of E2F-dependent genes in ACMs 
is associated with H3K9me3 and 
heterochromatin formation
To clarify the expression pattern of cell cycle genes in cardiac 
myocytes, we compared expression levels of cell cycle genes in 
purified embryonic (embryonic day 15.5 [E15.5]) cardiac myo-
cytes, ACMs, and growth-stimulated ACMs. To provide a growth 
stimulus for ACMs in vivo, trans-aortic constriction (TAC) was 
performed, which leads to pressure overload and primarily hyper-
trophic growth. Embryonic cardiac myocytes expressed high 
levels of all cell cycle genes consistent with their proliferative 
Chromatin is remodeled into active (euchromatin) and si-
lent (heterochromatin) regions through covalent modification 
of DNA and histones. These modifications regulate chromatin 
structure and gene expression. Histone acetylation, established 
by histone acetyltransferases, generally correlates with gene ac-
tivation and is essential for animal development. Two distinct 
families of histone acetyltransferases, GCN5 and PCAF (P300/
CBP-associated factor; acetyltransferases of H3K9) and CBP 
and p300 (acetyltransferases of H3K18/27), have been demon-
strated to be involved in E2F-dependent gene expression, and 
the deletion of either of them in mice leads to early embryonic 
lethality (Lang et al., 2001; Roth et al., 2001; Wang et al., 2007; 
Jin et al., 2011). The role of histone acetylation in cardiac myo-
cytes has received much attention as a means of promoting eu-
chromatin (Shogren-Knaak et al., 2006) and activating gene 
expression in the heart (Haberland et al., 2009). In contrast, the 
role of histone methylation in cardiac growth has been largely 
ignored despite its critical role in regulating gene expression in 
many cell types. Both the position and the degree of methyla-
tion may either activate or silence gene expression (Martin 
and Zhang, 2005; Shi, 2007). In animals, both H3K9me2 and 
H3K9me3 are related to gene silencing (Krauss, 2008); how-
ever, H3K9me3 is found predominantly within heterochroma-
tin, whereas H3K9me2 is mostly associated with silent domains 
within the euchromatic regions (Peters et al., 2001; Lehnertz 
et al., 2003). H3K9me1 and H3K9me2 are catalyzed by the his-
tone methyltransferase G9a, whereas H3K9me3 is established 
by the histone methyltransferase Suv39h1 (Brenner and Fuks, 
2007; Chin et al., 2007), which is often expressed in senescence 
and postmitotic cells (Rice et al., 2003). Trimethylation of   
lysine 27 on histone H3 (H3K27me3) has also been associated 
with heterochromatin formation and transcriptional repression 
(Dillon, 2004). The establishment of H3K27me3 is a result of 
the methyltransferase activity of polycomb group multiprotein 
complexes PRC1 or PRC2. Ezh2, the catalytic subunit of PRC2, 
had  been  thought  to  be  the  sole  H3K27  methyltransferase 
(Schuettengruber et al., 2007). Recently, however, Ezh1 was 
also shown to have H3K27 methyltransferase activity (Shen 
et al., 2008). Ezh1 and Ezh2 form similar PRC2 complexes but 
exhibit contrasting repressive roles (Margueron et al., 2008). 
Ezh2 expression is associated with proliferation, whereas Ezh1 
is  typically  more  abundant  in  nonproliferative  adult  organs 
(Laible et al., 1997).
One of the primary mechanisms by which histone modifi-
cations transmit their biological signals is through binding of 
effector proteins that recognize distinct modifications (Fischle 
et al., 2003a; Daniel et al., 2005). H3K9me3 and H3K27me3 
are preferentially recognized by the chromodomain-containing 
proteins heterochromatin protein 1 (HP1; Lachner et al., 2001) 
or Pc2 (Fischle et al., 2003b; Min et al., 2003), respectively. 
HP1 is a family of proteins (, , and ) that plays an important 
role in gene silencing in many organisms (James and Elgin, 
1986; Kellum, 2003) by establishing and maintaining hetero-
chromatin (Daniel et al., 2005), but their role in the heart is un-
known. HP1 family members typically differ in their subcellular 
localization and interaction partners and thus likely have dis-
tinct cellular functions (Minc et al., 1999, 2001; Auth et al., 2006). 409 Epigenetic regulation of cardiac proliferation • Sdek et al.
Figure 1.  Silencing of E2F-dependent genes in ACMs is associated with heterochromatin formation and H3K9 and H3K27 trimethylation. (A) To quantify 
cell cycle genes in ACMs after a growth stimulus, semiquantitative RT-PCR was performed on total RNA isolated from purified primary cardiac myocytes at 
the indicated developmental time points or 7 d after TAC-induced pressure overload. ANP, atrial natriuretic peptide; AurKB, Aurora kinase B. (B) Western 
blots on nuclear extracts prepared from purified embryonic cardiac myocytes or ACMs demonstrate that histone H3 becomes hypoacetylated and accumu-
lates H3K9me3 and H3K27me3 modifications with cardiac differentiation. (C) Suv39h1 and Ezh1, along with Rb and p130, are up-regulated in ACMs.   
(D and E) ACM nuclei demonstrated large, dense heterochromatin foci that have a lack of H3K9/14Ac and are enriched for H3K9me3. Confocal microscopy 
was performed on myocardial sections from WT C57/BL6 embryonic (E15.5) and adult mice after immunostaining (red, troponin C [TnC]; green, indicated 
histone H3 modification; blue, DAPI). Bars, 5 µm. (F and G) H3K9me3 (F) and H3K27me3 (G) were increased at promoters of E2F-dependent cell cycle 
genes after cardiac terminal differentiation. For quantitation of changes, see Fig. S1. ChIP was performed using chromatin extracts from purified myocytes 
and PCR for E2F-dependent promoters.JCB • VOLUME 194 • NUMBER 3 • 2011   410
a developmental time point at which they were still cycling. The 
–myosin heavy chain (MHC [-MHC])–driven Cre transgenic 
mouse we used excised Rb genomic sequences in the perinatal 
period before cardiac myocytes were fully differentiated (Marino 
et al., 2000; MacLellan et al., 2005). These cardiac-specific 
Rb-deficient mice (CRb
L/L) were bred to mice with a germline 
deletion of p130. Deletion of both Rb and p130 in cardiac myo-
cytes led to marked defects in differentiation and cell cycle   
exit, whereas the single deletions were innocuous (MacLellan 
et al., 2005). To determine the role of Rb and p130 in hetero-
chromatin formation in cardiac myocytes, we examined hearts   
from single or combined Rb and p130 knockout mice. We exam-
ined myocardial sections from control (CRb
+/+;p130
+/+), cardiac-
specific Rb-deficient mice (CRb
L/L;p130
+/+), p130-deficient 
mice  (CRb
+/+;p130
/),  or  double  Rb;p130-deficient  mice 
(CRb
L/L;p130
/;  Fig.  2  A).  Heterochromatin  formation  was 
disrupted specifically in CRb
L/L;p130
/ hearts. No abnormal-
ities were seen in single Rb- or p130-deficient hearts (Fig. 2 A). 
Immunostaining of myocardial sections demonstrated typical 
heterochromatin aggregates in control myocyte nuclei; however, 
heterochromatin was absent, and H3K9me3 immunostaining was 
diffuse in Rb;p130-null myocyte nuclei (Fig. 2 B). H3K27me3 
levels were dramatically decreased in CRb
L/L;p130
/ myocar-
dium (Fig. 2 C). Although these results support the notion that 
Rb and p130 are required for controlling cell cycle exit in the 
cardiac myocyte, this mouse model cannot distinguish between 
a primary role for them in initiating terminal differentiation and 
heterochromatin formation in cardiac myocytes versus a secondary 
defect related to persistent expression of cell cycle proteins and 
a persistent immature state. Also, this model could not determine 
whether Rb and p130 are also required for the maintenance of 
terminal differentiation and heterochromatin once formed.
Creation of cardiac-specific Rb and p130 
inducible double knockout (IDKO) mice
To determine the role of Rb and p130 more directly on hetero-
chromatin and maintenance of the postmitotic state in fully   
differentiated ACMs, we created inducible, cardiac-specific dou-
ble knockout mice. Rb
L/L;p130
/ mice were bred to -MHC–
MerCreMer  (MCM)  mice  to  generate  MCM
+;Rb
L/L;p130
/  
mice, in which Rb can be selectively and efficiently deleted in 
ACMs after Cre is activated by tamoxifen (TAM). Adult (8 wk   
after birth) MCM
;Rb
L/L;p130
+/+, MCM
+;Rb
L/L;p130
+/+, MCM
; 
Rb
L/L;p130
/,  and  MCM
+;Rb
L/L;p130
/  littermates  display 
normal heart weight to body weight ratio and left ventricle 
function before TAM treatment. There were no differences in 
expression of cell cycle genes or histone methylations (Fig. S2, 
A–C),  indicating  that  neither  p130  deletion  nor  expression   
of  MCM  by  themselves  had  any  epigenetic  effect.  Adult 
MCM
;Rb
L/L;p130
+/+,  MCM
+;Rb
L/L;p130
+/+,  MCM
;Rb
L/L; 
p130
/, and MCM
+;Rb
L/L;p130
/ littermates were fed with 
TAM chow for 14 d, resulting in four functional phenotypes: 
control, Rb-, p130-, and Rb/p130-deficient (IDKO) mice (Fig. 3, 
A and B). The minor amount of residual Rb expression likely 
represents the low level expression of Rb in nonmyocytes as 
well as unrecombined Rb in a minority of ACMs. Unless   
specifically indicated, analyses were performed 4 wk after 
state (Fig. 1 A). Although G1/S genes (CycD1 and Myc) were 
up-regulated in ACMs after pressure overload in vivo, expres-
sion  of  the  subset  of  cell  cycle  genes  that  regulates  G2/M 
(CycB1, cdc2, and cdc25C) and cytokinesis (Aurora kinase B 
and pololike kinase 1 [PLK1]) was not detectable in ACMs and 
remained unchanged after TAC, whereas pressure overload in 
ACMs resulted in up-regulation of the ventricular hypertrophy 
marker atrial natriuretic peptide (also known as atrial natriuretic 
factor [ANF]; Fig. 1 A). We examined embryonic cardiac 
myocytes or ACMs for the developmental pattern of histone 
modifications and the expression of proteins that regulate these 
posttranslational modifications. H3K9me2/3 and H3K27me3, 
the histone modifications associated with transcription repres-
sion, are increased in ACMs, whereas histone modifications   
associated with active gene expression (H3K9/14Ac, H3K18Ac, 
and H3K27Ac) and mitosis (phosphorylation of histone H3S10) 
are  decreased  (Fig.  1  B).  Consistent  with  these  alterations, 
H3K9 and H3K27 methyltransferases G9a, Suv39h1, and Ezh1, 
along with Rb and p130, are up-regulated in ACMs (Fig. 1 C).
To determine whether heterochromatin aggregation accu-
mulates with cardiac differentiation, we examined DNA in 
embryonic cardiac myocytes (E15.5) versus ACM nuclei for 
heterochromatin (Fig. 1 D). DNA within embryonic cardiac 
myocyte nuclei was homogeneously dispersed with limited 
DAPI-positive foci indicative of heterochromatin. In contrast, 
>90% of ACM nuclei demonstrated large, dense DAPI-positive 
heterochromatin foci. To further characterize these DNA foci, 
we immunostained cardiac nuclei for euchromatin (H3K9/14Ac) 
and heterochromatin (H3K9me3) markers (Figs. 1 E and S1 A). 
H3K9/14Ac was largely excluded from the dense DAPI-positive 
foci in ACMs, whereas H3K9me3 was concentrated in these 
DNA foci. H3K9me2 and H3K27me3 staining was found through-
out nuclei in both euchromatic and heterochromatic regions,   
although the levels of these modifications increased dramatically 
from embryonic cardiac myocytes (E15.5) to ACMs (Fig. 1 E). 
To determine whether the H3K9me3 or H3K27me3 was associ-
ated with E2F-dependent promoters, isolated myocytes from 
embryonic or adult hearts were cross-linked, and H3K9me3- 
and H3K27me3-associated promoter sequences were deter-
mined by chromatin immunoprecipitation (IP [ChIP]). As shown, 
H3K9me3  and  H3K27me3  were  enriched  at  E2F-dependent 
G2/M (cdc2) and cytokinesis (PLK1) promoters in ACM com-
pared with embryonic cardiac myocytes (Figs. 1 [F and G] and 
S1 [B and C]). Because H3K9 and H3K27 were also trimethyl-
ated at the promoter of Myc, which is up-regulated with hyper-
trophic stimuli, it suggests that, if H3K9me3 and H3K27me3 
contribute to permanent gene silencing in ACMs, additional 
factors must be required.
Rb and p130 play an overlapping role in the 
establishment of heterochromatin formation 
in differentiating cardiac myocytes
There is well-documented redundancy in Rb family members 
(Lee et al., 1996), and our own data have demonstrated that de-
fects in cardiac cell cycle control required deletion of both Rb 
and p130 (MacLellan et al., 2005). We used a cardiac-specific 
Cre/loxP system to delete Rb specifically in cardiac myocytes at 411 Epigenetic regulation of cardiac proliferation • Sdek et al.
Histological examination of IDKO myocardium revealed large, 
hyperchromatic nuclei, consistent with cycling cells (Fig. 3 C). 
There was no increase in myocardial fibrosis or apoptosis ob-
served in IDKO hearts (Fig. S3, B and C). Although normal at 
the baseline, IDKO mice developed left ventricle dilation and 
systolic dysfunction after TAM treatment (Table I). This con-
tractile defect was intrinsic to the myocytes themselves, as 
fractional shortening of isolated IDKO ACMs was reduced 
(Fig. S3 D).
stopping TAM to avoid any nonspecific (NS) effects related to 
treatment (Koitabashi et al., 2009). Fetal cardiac genes, includ-
ing ANF, -MHC, and skeletal -actin, were up-regulated spe-
cifically in IDKO hearts, whereas the cardiac genes (such as 
cardiac  -actin  and  -MHC)  that  were  predominantly  ex-
pressed in the ACMs remained unchanged (Fig. 3 B). IDKO 
ACMs reexpressed a panel of fetal cardiac-specific genes, in-
cluding a 3.7-fold increase in ANF, a threefold increase of   
-MHC, and a 2.3-fold increase of skeletal actin (Fig. S3 A). 
Figure 2.  Rb and p130 have overlapping roles in the establishment of heterochromatin and H3K27me3 in differentiating cardiac myocytes. (A–C) Con-
focal microscopy was performed on myocardial sections from adult mice with the indicated genotypes (red, troponin C; green, indicated H3K9 or H3K27 
modification; blue, DAPI). (A and B) Formation of H3K9me3-enriched heterochromatic foci was disrupted specifically in ACMs from CRb
L/L;p130
/ mice. 
Panels e–h are enlarged images of the boxed areas in panels a–d. Bars, 5 µm. (C) H3K27me3 levels were dramatically decreased in CRb
L/L;p130
/ 
myocardium compared with CRb
+/+;p130
+/+ myocardium. Bar, 25 µm.JCB • VOLUME 194 • NUMBER 3 • 2011   412
stimuli. However, Rb-deficient ACMs do not reenter the cell 
cycle after growth stimuli, indicating that H3K9me2 is not suf-
ficient for permanent cell cycle arrest. This reexpression of 
proliferation-promoting genes was associated with a marked 
reduction in the number of ACMs displaying heterochromatin 
aggregation (90 ± 1% in control ACMs vs. 14 ± 2% in IDKO 
ACMs, P < 0.01; Fig. 4, C and D). Consistent with the loss of 
heterochromatin, H3K9me3 immunostaining was diffuse in IDKO 
myocyte nuclei (Fig. S4 B). To determine whether depleting Rb 
and p130 also altered H3K9me3 or H3K27me3 at E2F-dependent 
promoters,  isolated  ACMs  from  IDKO  and  control  hearts   
were cross-linked, and H3K9me3- and H3K27me3-associated   
promoter  sequences  were  determined  by  ChIP.  As  shown, 
H3K9me3 and H3K27me3 levels at these E2F-dependent pro-
moters remained unchanged (Fig. 4, E and F), suggesting that 
Rb and p130 are dispensable for maintaining these two types of 
histone modifications in ACMs.
Depletion of Rb and p130 in ACMs 
derepresses G2/M and cytokinesis genes 
and disrupts heterochromatin aggregation
To determine whether Rb and p130 are involved in cell cycle 
gene silencing in postmitotic ACMs, expression of E2F-dependent 
genes was examined in IDKO mice. There was a 7–27-fold   
increase in expression of cell cycle genes in IDKO hearts com-
pared with control mice, including genes involved in regulating 
G2/M and cytokinesis, which were stably silenced in control 
ACMs (Figs. 4 A and S4 A). Phosphorylation of H3S10, which 
is characteristic of G2/M, was also increased in IDKO hearts, 
but  there  was  no  change  in  global  levels  of  H3K9me3  and 
H3K27me3 (Figs. 4 B and S4 [B and C]). Levels of H3K9me2, 
as well as G9a, the H3k9me2-specific methyltransferase, were 
decreased in ACMs from single Rb-deficient or IDKO mice, 
correlating with the up-regulation of G1/S cell cycle genes 
(cyclin E1 and E2F), which were regulated with hypertrophic 
Figure 3.  Creation of IDKO mice. (A) A Western blot using nuclear extracts prepared from ventricles of the indicated genotypes and demonstrating reduc-
tions in Rb protein levels after TAM treatment. (B) Expression of fetal cardiac-specific genes is up-regulated specifically in IDKO hearts. Semiquantitative 
RT-PCR was performed on total RNA extracted from purified ACMs with the indicated genotypes. For quantitation of changes in gene expression, see   
Fig. S3 A. CaA, cardiac actin; SkA, skeletal actin. (C) Hematoxylin and eosin staining of myocardial sections from mice with the indicated genotypes 1 
wk after TAM treatment. Bars, 40 µm.413 Epigenetic regulation of cardiac proliferation • Sdek et al.
gene  promoters,  resulting  in  their  incorporation  into  hetero-
chromatin (Nielsen et al., 2001; Narita et al., 2003). All three 
HP1 family members are expressed in ACMs, although their 
subnuclear localization differs (Fig. 6 A). HP1- and HP1-  
localize  in  both  euchromatin  and  heterochromatin,  whereas 
HP1- is restricted to heterochromatin (Fig. 6 A). To study the 
role of HP1 family members on irreversible cell cycle exit in 
postmitotic ACMs, we depleted expression of specific HP1s in 
primary wild-type (WT) ACMs using siRNA and then stimu-
lated the myocytes with serum to induce cell cycle reentry. 
Cells transfected with NS siRNA were used as a negative con-
trol. Each siRNA was able to specifically and effectively knock 
down expression of the respective HP1 (Fig. 6 B); however, ex-
pression of G2/M and cytokinesis genes only increased in HP1-
–depleted ACMs (P < 0.05; Fig. 6, B and C). There was no 
change in the expression of Myc and ANF, which are not stably 
silenced in ACMs. Because HP1- associates with the Rb pro-
tein in ACMs (Fig. 6 D), it is an excellent candidate to mediate 
the stable silencing of G2/M and cytokinesis genes in ACMs.
We further examined the role of HP1- in cardiac myo-
cyte cell cycle regulation by determining the effects of deplet-
ing  HP1-  in  neonatal  rat  ventricular  myocytes  (NRVMs). 
NRVMs were transfected with NS or HP1- siRNA. After 48 h, 
cells were collected for Western blot analysis (Fig. 6 E) or stim-
ulated with serum in the presence of BrdU (Fig. 6 F). Western 
blotting demonstrated efficient and specific HP1- knockdown. 
S phase myocyte nuclei were increased in HP1- siRNA– 
transfected cells compared with those transfected with NS siRNA 
(10.11 ± 1.79 vs. 2.34 ± 0.42%, P < 0.001; Fig. 6 G). To deter-
mine whether DNA synthesis is followed by cytokinesis in these 
myocytes, we also quantified total cell number after serum stimu-
lation. Depletion of HP1- resulted in a 56% increase in the 
NRVM cell number (P < 0.05; Fig. 6 H).
HP1 recruitment to genomic sites classically occurs by 
binding to H3K9me3 at specific target genes (Bannister et al., 
2001). However, HP1- also interacts with Rb, and H3K9me3 
was not altered at G2/M and cytokinesis gene promoters in 
IDKO ACMs (Fig. 4 E). Thus, we examined whether depleting 
Rb and p130 might prevent recruitment of HP1-, despite the 
presence of H3K9me3. ChIP for HP1- was performed on iso-
lated control and IDKO ACMs. HP1- was bound to cdc2 and 
IDKO ACMs spontaneously proliferate
To determine the effects of depleting Rb and p130 on cardiac myo-
cyte growth and proliferation, we examined heart size and indices 
of cell cycle progression. When we examined hearts 4 wk after 
completing the TAM treatment, IDKO hearts displayed a 32%   
increase in the heart weight to body weight ratio compared with 
control heart (6.01 ± 0.37 vs. 4.55 ± 0.11 mg/g, P < 0.05; Fig. 5 A), 
which  was  directly  attributable  to  an  increase  in  heart  weight   
(Fig. S5 B). To determine whether this increase in heart size was 
related to hypertrophy or proliferation of ACMs, we measured the 
cell size of isolated ACMs from control versus IDKO hearts. IDKO 
ACMs displayed a typical rod-shaped morphology but were 5% 
smaller than control ACMs (Figs. 5 B and S5 [A, C, and D]), sug-
gesting that the increased heart size must be related to ACM prolif-
eration. To confirm that ACMs in IDKO hearts were cycling, we 
determined S phase nuclei at the baseline or after hemodynamic 
stress. ACMs in the sham (a control surgical procedure similar to 
TAC)-operated IDKO myocardium demonstrated a 27-fold in-
crease in BrdU-positive myocyte nuclei compared with the control 
myocardium (P < 0.001), which increased to 70-fold after pressure 
overload (P < 0.001; Fig. 5, C and D). Notably, BrdU staining was 
only detected in cardiac myocytes that had lost heterochromatin 
foci (Fig. S5 E). We further assessed the proliferation potential of 
isolated IDKO ACMs by time-lapse video microscopy (TLVM;   
Fig. 5 E and Video 1). ACMs from control or IDKO hearts were 
cultured for 8 d, and cardiac myocyte nuclei were identified by in-
fection with an adenovirus expressing a cardiac-specific histone 
2B–GFP fusion protein. ACMs lose their typical rod-shaped mor-
phology and dedifferentiate when cultured for extended periods of 
time (Bersell et al., 2009), but this occurred more rapidly in IDKO 
myocytes. After 8 d in culture, 5.4% of IDKO ACMs completed 
cytokinesis during the 24-h monitoring period compared with zero 
control ACMs (P < 0.01), confirming that the proliferative poten-
tial of IDKO myocytes was restored.
Rb/p130-dependent recruitment of HP1- 
to E2F-responsive promoters is essential 
for irreversible silencing of proliferation-
promoting genes in ACMs
It has been suggested that the ability of Rb to stably repress 
transcription is related to its capacity to recruit HP1 to target 
Table I.  Assessment of left ventricular size and function
Parameter MCM
;Rb
L/L;p130
+/+ MCM
+;Rb
L/L;p130
+/+ MCM
;Rb
L/L;p130
/ MCM
+;Rb
L/L;p130
/
TAM + + + +
HR (bpm) 477 ± 6 473 ± 14 475 ± 16 480 ± 12
EF (%) 56.13 ± 2.02 50.40 ± 2.65 56.39 ± 3.32 33.52 ± 2.81
a
FS (%) 28.88 ± 1.29 25.32 ± 1.59 29.13 ± 2.31 15.97 ± 1.50
a
LVID;d (mm) 3.87 ± 0.07 3.98 ± 0.15 3.76 ± 0.02 4.78 ± 0.28
a
LVID;s (mm) 2.74 ± 0.08 2.98 ± 0.16 2.67 ± 0.08 4.02 ± 0.28
a
LVPW;d (mm) 0.63 ± 0.03 0.65 ± 0.14 0.67 ± 0.02 0.78 ± 0.03
a
LVPW;s (mm) 0.89 ± 0.02 0.89 ± 0.03 0.89 ± 0.02 0.78 ± 0.03
a
2D echocardiographic analysis of left ventricle function in mice with the indicated genotypes 4 wk after TAM treatment. n = 5 mice per group. Results are presented 
as the mean ± SEM. HR, heart rate; EF, ejection fraction; FS, fractional shortening; LVID;d/s, left ventricular internal dimension in diastole/systole; LVPW;d/s, left 
ventricular posterior wall thickness in diastole/systole.
aP < 0.05 by analysis of variance for MCM
;Rb
L/L;p130
+/+, MCM
+;Rb
L/L;p130
+/+, and MCM
;Rb
L/L;p130
/ versus MCM
+;Rb
L/L;p130
/ littermates.JCB • VOLUME 194 • NUMBER 3 • 2011   414
Figure 4.  Rb and p130 play an overlapping role in the silencing of proliferation-promoting genes and the maintaining of heterochromatin in ACMs.  
(A) Reexpression of G2/M and cytokinesis genes in IDKO hearts. Semiquantitative RT-PCR was performed on total RNA isolated from ventricular tissue 
from mice with the indicated genotypes. For quantitation of changes in gene expression, see Fig. S4 A. AurKB, Aurora kinase B. (B) Western blotting 
demonstrates that H3K9me3 and H3K27me3 levels are unchanged in IDKO ventricles. Also see Fig. S4 (B and C) for H3K9me3 and H3K27me3 levels in 
isolated ACMs determined by immunostaining. (C) Heterochromatin was disrupted only in ACMs from IDKO mice. Confocal microscopy was performed 
on myocardial sections (red, troponin C [TnC]; blue, DAPI). Bar, 10 µm. (D) Percentages of heterochromatin-positive nuclei were quantified in ACMs 
isolated from hearts with the indicated genotypes and treatment (n = 3 per group; *, P < 0.0001). Error bars represent the SEM. CM, cardiac myocyte. 
(E and F) H3K9me3 (E) and H3K27me3 (F) levels at E2F-dependent promoters remained unchanged in IDKO ACMs, as analyzed by ChIP using chromatin 
extracts from purified myocytes.
PLK1 promoters in control ACMs, but this binding was dis-
rupted in IDKO myocytes (Fig. 7, A and B). This was not re-
lated to lower levels of the HP1- protein, as expression of 
HP1- was increased in IDKO ACMs compared with control 
ACMs (Fig. 7 C). These results indicate that the recruitment of 
HP1- to promoters of cdc2 and PLK1 is Rb and p130 dependent. 415 Epigenetic regulation of cardiac proliferation • Sdek et al.
Figure 5.  IDKO ACMs spontaneously proliferate. (A) IDKO hearts displayed a 32% increase in heart weight to body weight ratio (HW/BW; n = 4 per 
group; *, P < 0.01). (B) Relative cell size of IDKO ACMs was 5% smaller than control ACM (n = 4 per group; *, P < 0.05). CM, cardiac myocyte. (C) Immuno-
fluorescence images of myocardial sections showing that IDKO ACMs reenter S phase in vivo (green, BrdU; red, troponin C; blue, DAPI). Bar, 40 µm.   
(D) Quantitation of BrdU labeling (n = 3 per group). *, P = 0.003 for sham-operated IDKO versus control; **, P < 0.0001 for TAC-operated IDKO versus 
control. (A, B, and D) Error bars represent the SEM. (E) IDKO cardiac myocytes complete cytokinesis in vitro. Histone 2B–GFP was expressed under control 
of the troponin T promoter (green) to visualize cardiomyocyte nuclei. The images were collected for 24 h at 15-min intervals (see Video 1). Bar, 15 µm.
Interestingly, HP1- is not present at the Myc promoter, which 
is up-regulated in ACMs in response to hypertrophic signals. 
Normal cellular localization of HP1 was disrupted in IDKO car-
diac myocytes (Fig. 7 D).
Rb/p130 is dispensable for  
Suv39h1-mediated H3K9me3
The fact that IDKO cardiac myocytes demonstrated persistent 
H3K9me3 at E2F-dependent promoters suggested that Rb/p130 JCB • VOLUME 194 • NUMBER 3 • 2011   416
of Suv39h1 on H3K9me3 levels in ACMs, siRNA was used to 
deplete Suv39h1 in control or IDKO cardiac myocytes. Tran-
sient transfection of Suv39h1 siRNA oligonucleotides into ACMs 
efficiently reduced expression of Suv39h1 (Fig. 8, A and B), which 
deletion did not affect H3K9me3 methylation. Recent studies 
have suggested that, in contrast to earlier studies (Nielsen et al., 
2001),  Suv39h1-dependent  methylation  is  Rb  independent 
(Gonzalo et al., 2005; Siddiqui et al., 2007). To clarify the role 
Figure 6.  HP1- is required for irreversible silencing of proliferation-associated genes in ACMs. (A) HP1-, -, and - are expressed in ACMs. (B) Semi-
quantitative RT-PCR shows that expression of cdc2 and PLK1 are increased when HP1- is depleted in ACMs with siRNA. si NS, NS siRNA. (C) Quantitation 
of data in B by real-time PCR. *, P = 0.002; **, P = 0.002; ***, P = 0.007. (D) IP assay demonstrates that Rb associates with HP1- in adult mice hearts. 
IB, immunoblotted. (E–H) NRVMs were transfected with NS or HP1- siRNA. After 48 h in serum-free media, cells were either collected for Western blot 
analysis (E) or stimulated with 20% FBS for 24 h in the presence of BrdU. (F) Cells were stained for BrdU and troponin C (TnC), and nuclei were counter-
stained with DAPI. Bar, 100 µm. (G and H) The percentage of BrdU-positive nuclei (G; *, P = 0.002) as well as total cell number (H; *, P = 0.038) was 
increased in HP1- siRNA–transfected NRVMs. Error bars represent the SEM from three replicates.417 Epigenetic regulation of cardiac proliferation • Sdek et al.
limited new cardiac myocyte formation, it arises from a non-
myocyte pool of progenitor cells (Davis et al., 2006; Bergmann 
et al., 2009). In the present study, we have investigated the 
molecular basis of this postmitotic state of ACM and demon-
strated that heterochromatin accumulates in ACMs as they lose 
proliferative potential. We show that Rb and p130 are critical 
for targeting and maintaining a subset of E2F-dependent genes 
in heterochromatin in ACMs. Rb and p130 permanently silence 
these G2/M and cytokinesis genes via the recruitment of HP1-, 
an essential component of heterochromatin to the promoters of 
these genes. Reversing these epigenetic changes was also asso-
ciated with reexpression of fetal cardiac genes, which we be-
lieve is analogous to the reexpression of Gata4 that was seen in 
dedifferentiated cardiac myocytes in zebrafish (Kikuchi et al., 
2010). Left ventricular dysfunction was also seen, but whether 
this is a direct consequence of the epigenetic manipulations we 
made or is a secondary effect related to the dedifferentiation of 
IDKO ACMs will need to be determined; however, the contractile 
resulted in a comparable reduction of H3K9me3 in both genotypes. 
Knockdown of Suv39h1 had a similar effect on cell cycle gene 
expression as was seen in HP1-–deficient cells (Fig. 8 B). 
Cdc2 and PLK1 mRNA levels increased 1.5–2-fold (P < 0.05). 
The binding of HP1 to H3K9 is Suv39h1 dependent (Bannister 
et al., 2001; Lachner et al., 2001; Peters et al., 2001). Prolifera-
tion-associated  genes  were  up-regulated  either  by  depleting 
Suv39h1 or Rb/p130, suggesting that both are required for per-
manent gene silencing by HP1- (Fig. 8 C).
Discussion
It has been recognized for some time that many lower verte-
brates have a robust capacity to regenerate organs, including the 
heart. This was felt to be lost in mammals, but a recent study 
has suggested that it is retained through embryonic and peri-
natal life (Porrello et al., 2011). However, it is clear that the adult 
mammalian heart has lost this regenerative capacity. If there is 
Figure 7.  Rb/p130-dependent recruitment of HP1- to E2F-responsive promoters is essential for irreversible silencing of proliferation-associated genes 
in ACMs. (A) HP1- bound to G2/M and cytokinesis genes in an Rb/p130-dependent manner as shown by ChIP using chromatin extracts from purified 
ACMs. (B) Quantitation of HP1- enrichment at the indicated promoters by real-time PCR. Error bars represent the SEM from three replicates. *, P = 0.018; 
**, P = 0.003. (C) A Western blot showing HP1-, -, and - expression in ventricles from mice with the indicated genotypes. (D) HP1- colocalized with 
heterochromatin in control ACM. IDKO ACM lost heterochromatin, and HP1- staining is diffused. TnC, troponin C. Bar, 5 µm.JCB • VOLUME 194 • NUMBER 3 • 2011   418
hyperacetylated (H3K9/14, H3K18, and H3K27), but, after 
adult differentiation, acetylation decreases, and histone methyl-
ation associated with transcriptional repression (H3K9me3 and 
H3K27me3) predominates.
The relationship of H3K9me3 and heterochromatin is well 
established, and recent studies (Bannister et al., 2001; Dillon, 
2004; Daniel et al., 2005; Grewal and Jia, 2007) have demonstrated 
that Suv39h1-mediated H3K9me3 and the binding of HP1 to 
H3K9me3  through  its  chromodomain  are  necessary  for  the   
assembly of facultative heterochromatin. Heterochromatin is a 
self-assembling framework of tethers (H3K9me3) and adaptors 
(HP1) where the HP1 molecules bound to different nucleo-
somes dimerize through their chromoshadow domains, leading 
to chromatin condensation (Grewal and Jia, 2007). Although 
depletion of Rb in p130-null ACMs disrupted heterochromatin 
formation globally (Fig. 4 C), there was no change in total or 
E2F-dependent, promoter-associated H3K9me3 or H3K27me3 
levels. This implies that these histone modifications may be re-
quired but are not sufficient for maintaining heterochromatin in 
ACMs. Superficially, these results seem to differ from a previ-
ous study (Nielsen et al., 2001) in nonmyocytes in which Rb was 
required for H3K9 methylation of E2F-dependent promoters. 
defect appears to be at the level of the myocyte (Fig. S3 D).   
Of note, heart regeneration in zebrafish, which occurs by car-
diac myocyte dedifferentiation and proliferation, is well tolerated, 
so this contractile defect associated with epigenetic dedifferen-
tiation in ACMs may underlie the reason why mammalian car-
diac myocytes have evolved to be postmitotic (Jopling et al., 
2010; Kikuchi et al., 2010).
Heterochromatin is a tightly packed and transcriptionally 
silent form of DNA, which comes in two varieties: constitutive 
and facultative. Constitutive heterochromatin is usually repeti-
tive and cell type independent and occurs around the chromo-
some centromere and near telomeres. In contrast, facultative 
heterochromatin is an acquired form that is cell type specific 
and is the result of genes that are silenced through histone   
methylation (Oberdoerffer and Sinclair, 2007). Although hetero-
chromatin formation has been reported in postmitotic skeletal   
myotubes, the effects of heterochromatin on the expression   
of proliferation-promoting genes were not determined (Brero   
et  al.,  2005).  Heterochromatin  has  a  characteristic  histone 
modification profile, which is distinguished by hypoacetylation 
and enrichment of H3K9me3. Our study demonstrates that   
the chromatin of proliferating embryonic cardiac myocytes is 
Figure 8.  Rb/p130 is dispensable for Suv39h1-mediated H3K9me3. (A) Rb/p130 deletion did not affect methyltransferase activity of Suv39h1 on H3K9. 
Comparable reduction of H3K9me3 was detected after depletion of Suv39h1 by siRNA in ACMs isolated from control and IDKO mice hearts 4 wk after 
TAM treatment. siNS, NS siRNA. (B) Semiquantitative RT-PCR demonstrating increased expression of cdc2 and PLK1 after Suv39h1 is depleted in ACMs 
with siRNA. CBP, cAMP response element-binding–binding protein. (C) A schematic model depicting Rb/p130-dependent epigenetic modifications associ-
ated with cell cycle gene regulation in embryonic cardiac myocytes and ACMs and Rb/p130-dependent heterochromatin formation in ACMs based on 
our results and published data (Roth et al., 2001; Daniel et al., 2005; Grewal and Jia, 2007; Jin et al., 2011). CM, cardiac myocyte; PCAF, P300/cAMP 
response element-binding CBP–associated factor.419 Epigenetic regulation of cardiac proliferation • Sdek et al.
including  nonconsensus  genomic  sequences  and  interactions   
of  E2F  with  other  factors  that  bind  to  the  target  promoters 
(Rabinovich et al., 2008). Binding of specific E2F family mem-
bers and their interactions with other factors can differentially 
regulate subsets of E2F-dependent cell cycle genes (Caretti 
et al., 2003). Determining how particular HP1 family members 
are recruited to specific subsets of genes and their differential 
effects on transcription is a critical question.
ACMs also displayed higher levels of H3K27me3, the 
other repressive histone mark associated with heterochromatin, 
compared with embryonic cardiac myocytes. We chose to focus 
on the regulation of H3K9me3, Rb, and HP1-, given their 
well-established roles in permanent gene silencing and localiza-
tion to heterochromatin. However, H3K27me3 can also be 
important for stable gene repression, including suppression of 
E2F-dependent genes, in certain contexts (Blais et al., 2007). 
Given that H3K27me3 is relatively enriched in ACM euchroma-
tin, not heterochromatin, it will need to be determined what role, 
if any, it has in heterochromatin formation in ACMs and whether 
it contributes to the irreversible cell cycle exit seen in ACMs.
In summary, we have demonstrated that epigenetic modi-
fications play a critical role in cardiac growth and differentia-
tion. Actively proliferating embryonic cardiac myocytes enriched 
for H3K9/14Ac express high levels of proliferation-promoting 
genes. Terminally differentiated ACMs express high levels of 
Rb and p130, which serve as a bridge to link H3K9me3 and 
heterochromatin formation through their interaction with HP1-. 
Heterochromatin stably represses the expression of proliferation-
promoting genes and maintains the postmitotic phenotype of 
ACMs (Fig. 8 C). The ability to restore ACMs’ proliferative   
potential in vivo could lead to regenerative approaches similar   
to what occurs naturally in zebrafish hearts (Jopling et al., 2010; 
Kikuchi et al., 2010). These findings have important implica-
tions for promoting regeneration of the injured mammalian hearts 
and suggest that epigenetic manipulation of cardiac myocytes 
may be a viable therapeutic approach.
Materials and methods
Animal studies
CRb
L/L;p130
/ mice have been previously described (MacLellan et al., 
2005).  To  create  inducible,  cardiac-specific  Rb-  and  p130-null  mice,   
Rb
L/L;p130
/  mice  were  bred  to  -MHC–MCM  mice,  resulting  in 
MCM;Rb
L/L;p130
+/ mice. Rb was deleted in ACMs after the Cre activation 
by TAM (Zhong et al., 2006). 8-wk-old mice carrying MCM were fed with TAM- 
containing  chow  (400  mg  TAM  citrate/kg  supplemented  standard  diet 
Global 2016 pellets; Harlan Teklad Europe) for 14 d. Experiments were 
performed 4 wk after stopping TAM treatment unless specifically indicated. 
For TAC, a fixed pressure overload was obtained by surgically constricting 
the transverse aorta as previously described (Xiao et al., 2001). In brief, 
adult  mice  weighing  20–25  g  were  anesthetized  by  an  i.p.  injection  of   
60 mg/kg sodium pentobarbital. Microsurgical procedures were performed 
under a dissecting microscope (PZM III; World Precision Instruments, Inc.).   
Endotracheal intubation was performed using a blunt 20-gauge needle that 
was then connected to a volume-cycled rodent ventilator (SAR-830/P; IITC Life 
Science) with a tidal volume of 0.2 ml and a respiratory rate of 120/min. The 
chest was entered in the second intercostal space at the top left aortic arch, the 
transverse aorta was isolated, and aortic constriction was performed by tying 
a 7–0 nylon suture ligature against a 20-guage needle. The needle was then 
removed to yield a constriction of 0.4 mm in diameter. All animals were han-
dled and maintained in accordance with institutional guidelines and the Na-
tional Institutes of Health Guide for the Care and Use of Laboratory Animals.
However, they are consistent with the conclusion that the re-
cruitment of HP1 to H3K9 methylation is Rb/p130 dependent. 
We have explored this issue in ACMs and demonstrated that 
deleting Rb reduced H3K9me2 but had no effect on H3K9me3 
levels (Fig. 4 B). Thus, whether the previous study was related 
to differences in the precise H3K9 methylation or was related to 
cell type–specific utilization or interaction of these factors will 
need to be determined. Regardless, our data suggest that H3K9me3 
alone is not sufficient to recruit HP1 in ACMs, and additional 
factors such as Rb family members are required for efficient 
binding. The ability to reverse the postmitotic state was also 
shown in a recent study in which concomitant inactivation of 
p14ARF and Rb led to skeletal myotube cell cycle reentry, loss 
of differentiation properties, and up-regulation of cytokinetic 
machinery (Pajcini et al., 2010). Although these authors did not 
examine the epigenetic impact of these gene manipulations, our 
data would suggest that Rb may be the key to recruiting a mul-
timeric chromatin-remodeling complex in postmitotic cells and 
explain why certain genes are specifically targeted for incorpo-
ration into heterochromatin. Irreversible growth arrest in myo-
genic differentiation requires the LXCXE-binding motif in Rb 
(Chen and Wang, 2000), indicating that at least one additional 
factor is necessary for Rb to induce terminal differentiation, as 
the LXCXE pocket is not required for Rb–E2F interactions. 
HP1 proteins contain an LXCXE (or LXCXD) motif (Williams 
and Grafi, 2000) and interact with both Rb and p130 (Panteleeva   
et al., 2007), and their recruitment to methylated H3K9 is Rb 
dependent (Nielsen et al., 2001).
HP1 belongs to a highly conserved family of chromatin 
proteins, with homologues that are found from fission yeast to 
mammals (Huisinga et al., 2006). The role of HP1 family mem-
bers during differentiation has received limited investigation but 
appears to be complex and developmentally dependent (Zhang 
et al., 2002; Cammas et al., 2004; Feldman et al., 2006; Agarwal 
et al., 2007; Panteleeva et al., 2007; Yahi et al., 2008; Takanashi 
et al., 2009). HP1- can negatively regulate differentiation by 
inhibiting tissue-specific factors at an early developmental stage 
(Zhang et al., 2002; Yahi et al., 2008) while promoting differen-
tiation at later stages by mediating repression of cell cycle genes 
and cell cycle exit (Panteleeva et al., 2007). We have detected 
the expression of all three family members of HP1 in post-
mitotic cardiac myocytes; however, depletion of HP1-, but not 
HP1- or HP1-, resulted in reexpression of E2F-dependent 
genes in ACMs. HP1- is also present at the promoters of G2/M 
and cytokinesis genes in ACMs, and this binding is Rb and 
p130 dependent. Loss of HP1- recruitment appeared to be the 
key factor in the disruption of heterochromatin and the ability to 
reenter the cell cycle. Our results demonstrate that HP1- is 
specifically essential for stably repressing proliferation-promoting 
genes in ACMs and, although HP1 family members share simi-
lar structure (HP1- and HP1-), could not compensate for the 
loss of function of HP1- in cardiac myocytes. This result dem-
onstrates that HP1 proteins, in contrast to Rb family members, 
are not functionally redundant. Why HP1- was specifically re-
cruited to G2/M and cytokinesis genes in ACMs versus other 
E2F-dependent promoters is unclear. However, E2F binding 
specificity to target promoters is effected by numerous factors JCB • VOLUME 194 • NUMBER 3 • 2011   420
mouse heart was incubated with 5 µg anti-Rb (G3-245; BD) at 4°C over-
night, and precipitates were subjected to Western blot analysis.
Antibodies to Rb (G3-245; BD), p130 (C-20; Santa Cruz Biotechnol-
ogy, Inc.), H3K9/14Ac (06-599; Millipore), H3K27Ac (07–360; Millipore), 
H3K9me2 (ab7312; Abcam), H3K9me3 (ab8898; Abcam), H3K27me3 
(07–449; Millipore), phosphor-Histone (Ser10, 04–817; Millipore), Ezh1 
(ab64850;  Abcam),  Ezh2  (39639;  Active  Motif),  G9a  (ab31874;   
Abcam), Suv39h1 (MG44; Millipore), HP1- (MAB3450; Millipore), phos-
phor-Histone (Ser10; Millipore), BrdU (ab6326; Abcam), tubulin (T8660; 
Sigma-Aldrich), Laminin B (Santa Cruz Biotechnology, Inc.), and H3   
(05–928; Millipore) were purchased commercially. Anti-H3K18Ac and -p107 
were provided by S.K. Kurdistani (University of California, Los Angeles, 
Los Angeles, CA).
Immunostaining and confocal analysis
Isolated cardiac myocyte cells were fixed with 4% PFA. Paraffin-embedded 
tissue sections or fixed cells were immunostained following standard proto-
cols. Antibodies to BrdU (ab6326), HP1- (15.19s2; Millipore), HP1- 
(MAB3448; Millipore), HP1- (MAB3450), troponin C (E-7; Santa Cruz 
Biotechnology, Inc.), troponin I (H-170; Santa Cruz Biotechnology, Inc.), 
and sarcomeric MHCs (MF20; Developmental Studies Hybridoma Bank) 
were purchased commercially. Phalloidin and secondary antibodies were 
purchased from Invitrogen.
Nuclei were visualized by DAPI staining. For calculation of hetero-
chromatin percentages, >100 nuclei per heart were examined by two in-
dependent blinded observers. Images were acquired with a microscope 
(Axiovert  200)  equipped  with  imaging  software  (AxioVision  4.6;  Carl 
Zeiss) at room temperature. A charge-coupled device camera (CoolSnap 
fx; Photometrics) was used for immunofluorescence staining, and a micros-
copy camera (AxioCam MRc; Carl Zeiss) was used for immunohistochem-
istry or immunocytochemistry staining. For confocal analysis, images were 
acquired with a true confocal scanner laser-scanning microscope system 
(SP2 AOBS; Leica) with 40× 1.3 NA and 63× 1.4 NA oil immersion ob-
jectives at room temperature. All images within the same panel were pro-
cessed similarly using Photoshop (version 6.0; Adobe).
siRNA and RNA analysis
ACMs  were  transfected  with  50  nM  HP1-  siRNA  or  negative  control 
siRNA (QIAGEN) by using Lipofectamine RNAiMAX (QIAGEN). 24 h after 
transfection, cells were stimulated with 20% FBS for 24 h. For RT-PCR, total 
RNA was isolated from cells or tissue using TRI Reagent (Sigma-Aldrich). 
First-strand cDNA was generated from 1 µg of total RNA by using a re-
verse transcription kit (Omniscript; QIAGEN). Real-time quantitative PCR 
was conducted using the ABI PRISM 7700 sequence detection system (Taq-
man; Applied Biosystems). PCR amplicons were detected by fluorescent 
detection of SYBR green (QuantiTect SYBR green PCR kit; QIAGEN). The 
siRNA oligonucleotide sequences used are as follows: HP1-, 5-GGC-
UUUUCUGAGGAGCACATT-3  (sense)  and  5-UGUGCUCCUCAAGA-
AAAGCCTT-3 (antisense); HP1-, 5-GGAAGCCAAUGUCAAGUGCTT-3 
(sense) and 5-GCACUUGACAUUGGCUUCCTT-3 (antisense); and HP1-,   
5-GCAGCGGAGAGUUAAUGUUTT-3  (sense)  and  5-AACAUUAACU-
CUCCGCUGCTG-3 (antisense). The Suv39h1 oligonucleotide sequences 
were previously published (Ait-Si-Ali et al., 2004). NS siRNA (QIAGEN) 
was used as a negative control.
ChIP
Isolated cardiac myocytes were fixed with 1% formaldehyde for 10 min at 
room temperature, and then 0.125 M glycine was added and incubated 
for 5 min at room temperature. To release the nuclei, cells were suspended 
in Mg-nonionic (NI)–NP-40 buffer (15 mM Tris-HCl, pH 7.5, 5 mM MgCl2, 
60 mM KCl, 0.5 mM DTT, 15 mM NaCl, 300 mM sucrose, and 1%   
NP-40) and incubated on ice for 20 min. Nuclei from the NP-40–lysed cells 
were spun down and washed in Ca-NI buffer (15 mM Tris-HCl, 1 mM 
CaCl2, pH 7.5, 60 mM KCl, 0.5 mM DTT, 15 mM NaCl, and 300 mM su-
crose). After they were spun down, pellets were resuspended in Ca-NI buf-
fer containing 25 µg/ml Staphylococcus aureus nuclease (Roche) and incu-
bated on ice for 30 min. After centrifugation at 3,500 rpm for 5 min at 
4°C, cell pellets were lysed by sonication on ice with nuclear lysis buffer 
(50 mM Tris-Cl, pH 8.1, 10 mM EDTA, 1% SDS, and protease inhibitors). 
After centrifugation at 13,000 rpm for 10 min at 4°C, the lysates were di-
luted 10 times with dilution buffer (0.01% SDS, 1.1% Triton X-100, 1.2 mM 
EDTA, 16.7 mM Tris-Cl, pH 8.1, 167 mM NaCl, and protease inhibi-
tor). After preclearing with 30 µl Protein A/G Dynabeads (Invitrogen), pri-
mary antibodies specific to H3K9me3 (Millipore), H3K27me3 (Millipore), 
and  HP1-  (MAB3450)  were  added  and  incubated  overnight  at  4°C.   
Isolation and analysis of cardiac myocytes
Isolation of ACMs was performed by collagenase/protease digestion as 
previously described (Mitra and Morad, 1985; Pott et al., 2005). 9–13-
wk-old mice were i.p. injected with heparin (2,000 U/mouse). 20 min   
after heparin injection, the heart was removed from the chest, cannulated 
via the ascending aorta, and mounted on a Langendorff perfusion appa-
ratus. The heart was perfused for 4 min with myocyte buffer at 37°C. 
Then, the perfusion was switched to an enzyme solution containing 1.0 
mg/ml collagenase type 2 (Worthington Biochemical Corp.), 0.1 mg/ml 
protease XIV (Sigma-Aldrich), and 0.015 mg/ml DNase I grade 2 (Roche). 
After 2 min of perfusion, the enzyme solution was supplemented with   
40 µl of 100 mM CaCl2, and perfusion was continued for another 8 min.   
After atria and aorta were removed, the ventricles were cut into two pieces 
and disaggregated with forceps (No. 5/45; Dumont) in 5 ml enzyme solu-
tion. The resulting tissue cell suspension was transferred to a 15-ml conical 
tube and incubated for 3–5 min to allow for further digestion. Digestion 
was stopped by adding 5 ml of stopping buffer (myocyte buffer plus 2.5% 
BSA and 0.1 mM CaCl2). After isolation, the dissociated cells were col-
lected in modified Tyrode’s solution containing the following (in mmol/ 
liter): 136 NaCl, 5.4 KCl, 10 Hepes, 1.0 MgCl2, 0.33 NaH2PO4, 0.2 
CaCl2, 10 dextrose, and 10 2,3-butanedione monoxime, pH 7.4, with 
NaOH. The cells were pelleted at 18 g for 2 min, resuspended in plating 
medium, and plated on 10 µg/ml Laminin-coated flasks (Invitrogen) or 
chamber slides to allow attachment. After 2 h, serum-containing plating 
media were switched to culture media (Kabaeva et al., 2008). The culture 
media were prepared by supplementing MEM (Invitrogen) with 1% peni-
cillin-streptomycin-glutamine  (PSG;  Invitrogen),  1%  insulin-transferrin- 
selenium (ITS; Sigma-Aldrich), 4 mM NaHCO3, 10 mM Hepes, 0.2% 
BSA, and 25 µM blebbistatin (Toronto Research Chemicals). Culture me-
dia were changed every day. Plating media were supplemented with 5% 
FBS (Invitrogen). To measure ACM size, the phase-contrast images of iso-
lated ACM were acquired using a microscope (Axiovert 200; Carl Zeiss), 
and cell size was calculated using ImageJ (National Institutes of Health). 
100 ACMs per heart were examined for cell size. Fetal mouse ventricular 
myocytes and NRVMs were isolated as previously described (Ueno et al., 
1988). Fetal mouse cardiac myocytes were prepared from ventricles of 
E15.5 mice embryos, and NRVMs were prepared from the ventricles of   
2-d-old Sprague-Dawley rats. In brief, cells were isolated by four cycles   
of enzymatic digestion with gentle mechanical disaggregation. Cells were 
dissociated at 37°C and 40 rpm in Ca
2+- and Mg
2+-free PBS supplemented 
with 0.1% trypsin, 0.1% collagenase, and 0.025% DNAase (Worthing-
ton Biochemical Corp.). After the final cycle of digestion, the dissociated 
cells were pooled and purified by density centrifugation through a discon-
tinuous Percoll gradient (GE Healthcare). Cells were then resuspended in 
culture medium (DME: M199 = 4:1, 1% PSG, and 1% ITS) containing 
10% neonatal calf serum (Invitrogen) and plated on polystyrene culture 
dishes treated with 0.1% gelatin (ICN Biochemicals, Inc.). After 12–16 h, 
NRVMs were maintained in culture in serum-free medium.
Histological analysis and BrdU studies
For histology, hearts were fixed overnight in 10% buffered formalin and 
then routinely processed. To quantify DNA synthesis, sham or TAC was 
performed 1 wk after TAM treatment. 5 d after surgery, mice were injected 
with 50 mg/kg BrdU every 12 h for 2 d. The animals were euthanized, 
and their hearts were recovered 4 h after the last injection. For in vitro stud-
ies, NRVMs were transfected with HP1- siRNA or negative control siRNA. 
After a further 48 h in serum-free media, cultures were stimulated with 20% 
FBS in the presence of 10 µm BrdU labeling reagent. Then, cells were fixed 
and subjected to immunostaining.
Protein analyses
Heart tissue, isolated embryonic cardiac myocytes, or ACMs were used to 
obtain nuclear extracts. Heart tissues were homogenized in homogeniza-
tion buffer (250 mM sucrose, 10 mM Tris, pH 7.4, 1 mM EDTA, 0.5% NP-
40, 1 mM Na3VO4, 1 mM NaF, and protease inhibitor cocktail). Isolated 
cardiac myocytes were resuspended in homogenization buffer and centri-
fuged at 1,000 g for 10 min at 4°C. Pellets were resuspended in 0.3 ml 
homogenization  buffer,  layered  on  1  M  sucrose,  and  recentrifuged  at 
1,600 g for 5 min at 4°C. The nuclear protein was extracted with sonica-
tion in EBC250 buffer (25 mM Tris-HCl, pH 8.0, 250 mM NaCl, 1 mM 
NaF, 1 mM Na3VO4, 0.5% NP-40, and protease inhibitor). Equal amounts 
of nuclear protein (5–50 µg) were separated on SDS-PAGE gels, trans-
ferred to polyvinylidene fluoride membrane, and hybridized using an ap-
propriate primary antibody and HRP-conjugated secondary antibody for 
subsequent detection by ECL. For IP, 1 mg nuclear extract from an adult 421 Epigenetic regulation of cardiac proliferation • Sdek et al.
Online supplemental material
Fig. S1 shows heterochromatin formation in ACMs and is related to Fig. 1. 
Fig.  S2  shows  that  cardiac  myocytes  from  adult  MCM
;Rb
L/L;p130
+/+, 
MCM
+;Rb
L/L;p130
+/+,  MCM
;Rb
L/L;p130
/,  and  MCM
+;Rb
L/L;p130
/ 
mice differentiate normally before TAM treatment and is related to Fig. 3. 
Fig. S3 shows characterization of IDKO cardiac myocytes and is related to 
Fig. 3. Fig. S4 shows that proliferation-promoting gene expressions were 
up-regulated after depletion of Rb and p130 in ACMs; however, levels of 
H3K9me3 and H3K27me3 were unchanged. Fig. S4 shows up-regula-
tion of proliferation-promoting gene expression after depletion of Rb and 
p130 in ACMs and is related to Fig. 4. Fig. S5 shows characterization 
of cardiac growth in IDKO hearts and is related to Fig. 5. Video 1 shows 
that Rb- and p130-null ACMs complete cytokinesis in vitro and is related 
to Fig. 5. Online supplemental material is available at http://www.jcb 
.org/cgi/content/full/jcb.201012049/DC1.
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Real-time quantitative PCR
Real-time quantitative PCR was conducted using the ABI PRISM 7700 se-
quence detection system. PCR amplicons were detected by fluorescent de-
tection of SYBR green (QuantiTect SYBR green PCR kit). Error bars represent 
the SEM from three replicates.
TLVM
Freshly isolated ACMs were initially cultured in M199 medium supplemented 
with 5 mM creatine, 5 mM taurine, 2 mM l-carnitine, 1% PSG, 8% FBS,   
25 µM blebbistatin, and 10 µM cytosine -d-arabinofuranoside. After 48 h, 
blebbistatin was removed. After another 3 d, cytosine -d-arabinofuranoside 
was removed. Cells were infected with an adenovirus expressing a fusion 
construct of histone 2B–GFP under control of the chicken troponin T promoter 
(Ad–chicken troponin T–H2B-GFP; provided by F. del Monte, Beth Israel 
Deaconess Medical Center, Boston, MA) on day 7. 2 d after infection, TLVM 
was  performed  using  an  inverted  microscope  equipped  with  a  phase- 
contrast temperature-controlled motorized stage (DMIRE2; Leica). The 12.5-
cm
2 flask with an air-permeable cap was maintained on the stage at 37°C 
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Patch-clamp methods
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